GlucoLight

0 Comments Leave a Comment

1-15 of 22 // 1 2 »
Categories:
Application: Bronchoscopy, Cardiology, Dentistry, Dermatology, Endoscopy, Glucose, Microscopy, Non-Medical, Ophthalmology
Miscellaneous: Acquisition, Funding, Jobs & Studentships, Partnership, Patents

About GlucoLight

GlucoLight Corporation.  Glucose Monitoring.  GlucoLight is focused on the development of non-invasive medical monitoring products using Optical Coherence Tomography (OCT).  The company’s first development effort is SENTRIS-100 , a hospital-based monitor that will make continuous, non-invasive measurement and monitoring of blood glucose a reality. In four years, GlucoLight has taken the SENTRIS-100 from an idea to a working prototype currently in clinical trials, with a pivotal FDA trial expected to begin in 2008.  GlucoLight’s experienced management team comes from a broad cross section of business disciplines, including operations, finance, device technology, product development, and marketing. The company is led by CEO Ray Krauss, a 25-year veteran of the medical device industry and former executive with Johnson & Johnson.  The company’s start-up was supported by Ben Franklin Technology Partners of Northeastern Pennsylvania and Life Sciences Greenhouse of Central Pennsylvania, both sponsored by the Commonwealth of Pennsylvania. The company has also been financed by Matignon Technologies, one of the largest European venture funds focusing on medical technology.  Upon completion of SENTRIS-100 development for the hospital market, GlucoLight will focus on accelerating its development of a consumer monitor. GlucoLight does not market to, or make its devices available to the consumer market at this time.

  1. Mentioned In 22 Articles

  2. Newton Photonics wins NSF grant for new glucose meter

    masshightech.com (Nov 30 2008) Glucose , Funding Explore Article

    ...The market is there waiting for it.” However, Halevi noted that at least one other startup, GlucoLight Corp. of Bethlehem, Pa., is developing a similar product. He said Newton Photonics’ technology en... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Shmuel Halevi   Newton Photonics

  3. Newton Photonics Wins a NSF SBIR Grant for OCT Glucose Monitor

    Your Diabetes May Vary (Nov 28 2008) Glucose , Funding Explore Article

    ...“The market is there waiting for it.” However, Halevi noted that at least one other startup, GlucoLightCorp. of Bethlehem, Pa., is developing a similar product. He said Newton Photonics’ technology ena... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Shmuel Halevi   Newton Photonics

  4. Location, Location—Innovation: Companies in key U.S. regions continue to dominate medtech innovation, but the names on their patents often come with overseas addresses.

    Medical Device Link (Nov 21 2008) Explore Article

    ... this region most closely aligned with new science. Newly emerging medical device companies such as Glucolight Corp. (Bethlehem, PA) also have strong technologies rooted in scientific research. Glucolight's optical coherence tomography provides a more sophisticated means of continuous and noninvasive bl... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Boston Scientific   Cordis

  5. Report evaluates noninvasive glucose monitors, makers

    BioOptics World (Jun 10 2008) Glucose Explore Article

    Just this spring, one of those contestants -- GlucoLight, a development-stage company -- was awarded a US Patent (#7356365) for the non-invasive method and ... (Read Full Article)

    Comment on Article Mentions:   GlucoLight

  6. GlucoLight is currently looking for experienced electronics, mechanical, software and biomedical engineers to join its team.

    GlucoLight Corporation (Jun 4 2008) Jobs & Studentships Explore Article

    GlucoLight is currently looking for experienced electronics, mechanical, software and biomedical engineers to ... (Read Full Article)

    Comment on Article Mentions:   GlucoLight

  7. Optical Coherence Tomography-Based Continuous Noninvasive Glucose Monitoring in Patients with Diabetes

    Mary Ann Liebert, Inc. (May 14 2008) Glucose Explore Article

    ... glucose concentrations evaluated using simultaneous capillary and OCT-based device (Sentris-100^ , GlucoLight, Bethlehem, PA) measurements. Subjects received a 50-g carbohydrate load at the start of the study ... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Glucolight Sentris-100

  8. Optical coherence tomography-based continuous noninvasive glucose monitoring in patients with diabetes.

    NCBI HomePage (May 14 2008) Glucose Explore Article

    ... glucose concentrations evaluated using simultaneous capillary and OCT-based device (Sentris-100(), GlucoLight, Bethlehem, PA) measurements. Subjects received a 50-g carbohydrate load at the start of the study ... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Glucolight Sentris-100

  9. 35 Early- to Late-Stage Medical Device Company Presenters Seeking ...

    earthtimes.org (May 13 2008) Explore Article

    ...enix Pharmaceuticals, CVAC Systems, Inc., EyeGate Pharmaceuticals, Inc., Gel Delivery Solutions BV, GlucoLight Corporation, Healionics Corporation, ... NEWPORT BEACH, Calif. - (Business Wire) Medtech Insight, a... (Read Full Article)

    Comment on Article Mentions:   GlucoLight

  10. GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology

    -- Front | www.centredaily.com (Apr 25 2008) Glucose Explore Article

    ...onal clinical trials of its SENTRIS-100(TM) monitor in the second and third quarters of 2008. About GlucoLight Corporation Formed in 2003, GlucoLight is a development-stage company focused on continuous, non-invasive blood glucose monitoring in the ... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Ray Krauss   Matthew J. Schurman

  11. GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology

    businesswire.com (Apr 25 2008) Glucose Explore Article

    ...ional clinical trials of its SENTRIS-100™ monitor in the second and third quarters of 2008. About GlucoLight Corporation Formed in 2003, GlucoLight is a development-stage company focused on continuous, non-invasive blood glucose monitoring in the ... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Glucolight Sentris-100

  12. GlucoLight Awarded Patent for Tissue Oximetry Measurement Technology

    Free Services for PR (Apr 25 2008) Glucose Explore Article

    ...onal clinical trials of its SENTRIS-100(TM) monitor in the second and third quarters of 2008. About GlucoLight Corporation Formed in 2003, GlucoLight is a development-stage company focused on continuous, non-invasive blood glucose monitoring in the ... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Ray Krauss   Glucolight Sentris-100

  13. GlucoLight Corporation Raises Third Tranche Of ''c'' Round Financing

    businesswire.com (Mar 18 2008) Glucose , Funding Explore Article

    BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non-invasive, continuous blood glucose monitori... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Ray Krauss   Glucolight Sentris-100

  14. GlucoLight Corporation Raises Second Tranche of “c” Round Financing

    businesswire.com (Feb 14 2008) Glucose , Funding Explore Article

    ...entual consumer monitor. “This most recent influx of capital comes as we enter a pivotal time for GlucoLight and our SENTRIS-100 monitor,” said Ray Krauss, Chief Executive Officer of GlucoLight Corporation. “Our clinical tests through 2007 were successful in refining SENTRIS-100, as we made... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Ray Krauss   Glucolight Sentris-100

  15. GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing

    businesswire.com (Feb 14 2008) Glucose , Funding Explore Article

    BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non-invasive, continuous blood glucose monitori... (Read Full Article)

    Comment on Article Mentions:   GlucoLight   Ray Krauss   Glucolight Sentris-100

  16. OCT market set for rapid growth

    Medical Physics (Jan 16 2008) Funding Explore Article

    ...turing OCT systems. Those profiled in the report include Bioptigen, Carl Zeiss Meditec, Fox Hollow, GlucoLight, Heidelberg Engineering, OPKO, Optopol, Optovue, Topcon Medical Systems, Imalux, ISIS Optronics, La... (Read Full Article)

    Comment on Article Mentions:   LightLab Imaging   Lantis Laser   Imalux

1-15 of 22 // 1 2 »
Home All Articles Entities Quotes Comments Login Register Powered by HiveFire